STOCK TITAN

Point72 reports 958,768-share (5.7%) stake in Q32 Bio (QTTB)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Q32 Bio Inc. ownership update: Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen report shared voting and dispositive power over 958,768 shares of Common Stock, representing 5.7% of the class as of the close of business on May 14, 2026. The cover page footnote states that as of March 31, 2026 the reporting persons may have been deemed to beneficially own 0 shares. The filing attributes voting and investment power to Point72 Associates under an investment management agreement; Point72 Capital Advisors Inc. is the general partner and Mr. Cohen controls both entities.

Positive

  • None.

Negative

  • None.

Insights

Point72 reports a 5.7% shared position in Q32 Bio via managed fund.

Row 9 of the cover page lists 958,768 shares with shared voting and dispositive power reported as of May 14, 2026. The filing attributes ownership through Point72 Associates under an investment management agreement.

Implications depend on whether Point72 Associates trades or holds these shares; subsequent filings would show any changes in position or voting intent.

Control is reported via managed-account structure, not direct ownership.

The statement clarifies that Point72 Asset Management and Point72 Capital Advisors own no shares directly and report shared control over shares held by Point72 Associates. The filing includes the statement that it should not be construed as an admission of beneficial ownership under Section 13.

Watch for any future amendments or Form 13D/13G changes that disclose shifts in intent or additional control language.

Shared voting/dispositive power 958,768 shares as of May 14, 2026
Percent of class 5.7% as of May 14, 2026
CUSIP 746964105 Common Stock, par $0.0001
Cover page snapshot date May 14, 2026 information set forth on cover page
Footnote date March 31, 2026 footnote states may have been deemed to beneficially own 0 shares
beneficially own regulatory
"The information set forth on this cover page reflects information as of the close of business on May 14, 2026."
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared dispositive power financial
"Shared Dispositive Power 958,768.00"
investment management agreement regulatory
"Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
Schedule 13G/A regulatory
"This statement is filed by: (i) Point72 Asset Management ..."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Point72 report in QTTB (Q32 Bio)?

Point72 reports shared voting and dispositive power over 958,768 shares, equal to 5.7% of the class as of May 14, 2026. This position is held through Point72 Associates, an investment fund managed by Point72.

Who holds the reported voting and investment power for these QTTB shares?

The filing states Point72 Asset Management maintains investment and voting power over shares held by Point72 Associates; Point72 Capital Advisors Inc. is the general partner and Steven A. Cohen controls both entities.

Does Point72 directly own the reported QTTB shares?

No. The filing explicitly says Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own no shares directly; the reported power arises from an investment management agreement with Point72 Associates.

What do the March 31, 2026 footnote figures show?

The cover page footnote states that as of March 31, 2026 the reporting persons may have been deemed to beneficially own 0 shares of Common Stock, representing 0% of shares outstanding at that time.

Where is the issuer’s principal executive office listed?

The filing lists Q32 Bio Inc.'s principal executive office at 830 Winter Street, MA 02451 and provides Point72's business office at 72 Cummings Point Road, Stamford, CT 06902.





746964105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock (as defined in Item 2(a)), representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock, representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock, representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026